Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RIDR-PI-103 is a reactive oxygen species (ROS)-induced drug release prodrug containing an autocyclized portion linked to a pan-PI3K inhibitor (PI-103). In MDA-MB-361 and MDA-MB-231 cells, Doxorubicin and RIDR-PI-103 exhibited synergistic inhibition of cancer cell proliferation.
Description | RIDR-PI-103 is a reactive oxygen species (ROS)-induced drug release prodrug containing an autocyclized portion linked to a pan-PI3K inhibitor (PI-103). In MDA-MB-361 and MDA-MB-231 cells, Doxorubicin and RIDR-PI-103 exhibited synergistic inhibition of cancer cell proliferation. |
Molecular Weight | 511.53 |
Formula | C27H25N7O4 |
CAS No. | 2581114-71-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RIDR-PI-103 2581114-71-6 inhibitor inhibit